Business Description
OPKO Health Inc
NAICS : 339116
SIC : 2835
ISIN : US68375N1037
Total Employee Number:
2,275Description
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.86 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | -11.45 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.37 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.7 | |||||
3-Year EBITDA Growth Rate | 47.4 | |||||
3-Year EPS without NRI Growth Rate | 4.2 | |||||
3-Year FCF Growth Rate | -15 | |||||
3-Year Book Growth Rate | -6.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 31.34 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.88 | |||||
9-Day RSI | 70.84 | |||||
14-Day RSI | 67.59 | |||||
3-1 Month Momentum % | 9.37 | |||||
12-1 Month Momentum % | -1.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.61 | |||||
Quick Ratio | 3.17 | |||||
Cash Ratio | 2.3 | |||||
Days Inventory | 63.87 | |||||
Days Sales Outstanding | 57.78 | |||||
Days Payable | 49.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 8.74 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.98 | |||||
Operating Margin % | -34.9 | |||||
Net Margin % | -36.64 | |||||
EBITDA Margin % | -5.97 | |||||
FCF Margin % | -29.98 | |||||
OCF Margin % | -28.1 | |||||
ROE % | -16.67 | |||||
ROA % | -10.77 | |||||
ROIC % | -12.49 | |||||
3-Year ROIIC % | -0.36 | |||||
ROC (Joel Greenblatt) % | -65.18 | |||||
ROCE % | -6.98 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.02 | |||||
PB Ratio | 0.95 | |||||
Price-to-Tangible-Book | 38.5 | |||||
EV-to-EBIT | -9.62 | |||||
EV-to-EBITDA | -34.69 | |||||
EV-to-Revenue | 2.07 | |||||
EV-to-Forward-Revenue | 2.26 | |||||
EV-to-FCF | -6.9 | |||||
Price-to-GF-Value | 1.44 | |||||
Price-to-Projected-FCF | 12.83 | |||||
Price-to-Median-PS-Value | 1.35 | |||||
Earnings Yield (Greenblatt) % | -10.4 | |||||
FCF Yield % | -15.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OPKO Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 581.122 | ||
| EPS (TTM) ($) | -0.27 | ||
| Beta | 1.6574 | ||
| 3-Year Sharpe Ratio | -0.36 | ||
| 3-Year Sortino Ratio | -0.46 | ||
| Volatility % | 36.91 | ||
| 14-Day RSI | 67.59 | ||
| 14-Day ATR ($) | 0.062468 | ||
| 20-Day SMA ($) | 1.43657 | ||
| 12-1 Month Momentum % | -1.53 | ||
| 52-Week Range ($) | 0.9794 - 1.605 | ||
| Shares Outstanding (Mil) | 755.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OPKO Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OPKO Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 16:30 | In 123 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 122 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 16:30 | In 33 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 32 days | ||
| General meeting for 2026 | 2026-06-18 10:00 | 1.39 (-0.57%) | ||
| First quarter earnings conference call for 2026 | 2026-04-28 16:30 | 1.20 (+1.69%) | ||
| First quarter earnings results for 2026 | 2026-04-28 | 1.20 (+1.69%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 16:30 | 1.19 (+4.39%) | ||
| Annual report for 2025 | 2026-02-26 | 1.19 (+4.39%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 1.19 (+4.39%) |
Show
Entries
OPKO Health Inc Frequently Asked Questions
What is OPKO Health Inc(LTS:0KCS)'s stock price today?
The current price of LTS:0KCS is $1.54. The 52 week high of LTS:0KCS is $1.61 and 52 week low is $0.98.
When is next earnings date of OPKO Health Inc(LTS:0KCS)?
The next earnings date of OPKO Health Inc(LTS:0KCS) is 2026-07-31 Est..
Does OPKO Health Inc(LTS:0KCS) pay dividends? If so, how much?
OPKO Health Inc(LTS:0KCS) does not pay dividend.
Press Release
Articles on OPKO Health Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers